Toxicology Testing Services Market Size, Share, and Trends 2025 to 2034

Toxicology Testing Services Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Toxicology Testing Services Market 

5.1. COVID-19 Landscape: Toxicology Testing Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Toxicology Testing Services Market, By Method

8.1. Toxicology Testing Services Market, by Method

8.1.1. In Vitro Testing

8.1.1.1. Market Revenue and Forecast

8.1.2. In Vivo Testing

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Toxicology Testing Services Market, By Toxicity Endpoint & Test

9.1. Toxicology Testing Services Market, by Toxicity Endpoint & Test

9.1.1. ADME (Absorption, Distribution, Metabolism, and Excretion) Toxicology Testing

9.1.1.1. Market Revenue and Forecast

9.1.2. Genotoxicity

9.1.2.1. Market Revenue and Forecast

9.1.3. Skin Irritation, Corrosion & Sensitization

9.1.3.1. Market Revenue and Forecast

9.1.4. Cytotoxicity

9.1.4.1. Market Revenue and Forecast

9.1.5. Ocular Toxicity

9.1.5.1. Market Revenue and Forecast

9.1.6. Organ Toxicity

9.1.6.1. Market Revenue and Forecast

9.1.7. Dermal Toxicity

9.1.7.1. Market Revenue and Forecast

9.1.8. Phototoxicity

9.1.8.1. Market Revenue and Forecast

9.1.9. Endocrine Disruption

9.1.9.1. Market Revenue and Forecast

9.1.10. Carcinogenicity

9.1.10.1. Market Revenue and Forecast

9.1.11. Neurotoxicity

9.1.11.1. Market Revenue and Forecast

9.1.12. Immunotoxicity

9.1.12.1. Market Revenue and Forecast

9.1.13. Cytotoxicity

9.1.13.1. Market Revenue and Forecast

9.1.14. Drug Development Related Services

9.1.14.1. Market Revenue and Forecast

9.1.15. Substance Abuse and Addiction Testing

9.1.15.1. Market Revenue and Forecast

9.1.16. Therapeutic Drug Monitoring (TDM)

9.1.16.1. Market Revenue and Forecast

9.1.17. Other End Points & Tests

9.1.17.1. Market Revenue and Forecast

Chapter 10. Global Toxicology Testing Services Market, By Technology 

10.1. Toxicology Testing Services Market, by Technology

10.1.1. Cell Culture Technology

10.1.1.1. Market Revenue and Forecast

10.1.2. High-Throughput Screening (HTS) / High-Content Screening (HCS)

10.1.2.1. Market Revenue and Forecast

10.1.3. Toxicogenomics (Omics Technology)

10.1.3.1. Market Revenue and Forecast

10.1.4. Molecular Imaging Technology

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Toxicology Testing Services Market, By End-User Industry 

11.1. Toxicology Testing Services Market, by End-User Industry

11.1.1. Pharmaceutical and Biotechnology Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. Clinical Industry

11.1.2.1. Market Revenue and Forecast

11.1.3. Agrochemical Industry

11.1.3.1. Market Revenue and Forecast

11.1.4. Cosmetics and Household Products Industry

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Toxicology Testing Services Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Method

12.1.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.1.3. Market Revenue and Forecast, by Technology

12.1.4. Market Revenue and Forecast, by End-User Industry

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Method

12.1.5.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.1.5.3. Market Revenue and Forecast, by Technology

12.1.5.4. Market Revenue and Forecast, by End-User Industry

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Method

12.1.6.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.1.6.3. Market Revenue and Forecast, by Technology

12.1.6.4. Market Revenue and Forecast, by End-User Industry

12.2. Europe

12.2.1. Market Revenue and Forecast, by Method

12.2.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.2.3. Market Revenue and Forecast, by Technology

12.2.4. Market Revenue and Forecast, by End-User Industry

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Method

12.2.5.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.2.5.3. Market Revenue and Forecast, by Technology

12.2.5.4. Market Revenue and Forecast, by End-User Industry

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Method

12.2.6.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.2.6.3. Market Revenue and Forecast, by Technology

12.2.6.4. Market Revenue and Forecast, by End-User Industry

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Method

12.2.7.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.2.7.3. Market Revenue and Forecast, by Technology

12.2.7.4. Market Revenue and Forecast, by End-User Industry

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Method

12.2.8.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.2.8.3. Market Revenue and Forecast, by Technology

12.2.8.4. Market Revenue and Forecast, by End-User Industry

12.3. APAC

12.3.1. Market Revenue and Forecast, by Method

12.3.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.3.3. Market Revenue and Forecast, by Technology

12.3.4. Market Revenue and Forecast, by End-User Industry

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Method

12.3.5.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.3.5.3. Market Revenue and Forecast, by Technology

12.3.5.4. Market Revenue and Forecast, by End-User Industry

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Method

12.3.6.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.3.6.3. Market Revenue and Forecast, by Technology

12.3.6.4. Market Revenue and Forecast, by End-User Industry

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Method

12.3.7.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.3.7.3. Market Revenue and Forecast, by Technology

12.3.7.4. Market Revenue and Forecast, by End-User Industry

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Method

12.3.8.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.3.8.3. Market Revenue and Forecast, by Technology

12.3.8.4. Market Revenue and Forecast, by End-User Industry

12.4. MEA

12.4.1. Market Revenue and Forecast, by Method

12.4.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.4.3. Market Revenue and Forecast, by Technology

12.4.4. Market Revenue and Forecast, by End-User Industry

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Method

12.4.5.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.4.5.3. Market Revenue and Forecast, by Technology

12.4.5.4. Market Revenue and Forecast, by End-User Industry

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Method

12.4.6.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.4.6.3. Market Revenue and Forecast, by Technology

12.4.6.4. Market Revenue and Forecast, by End-User Industry

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Method

12.4.7.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.4.7.3. Market Revenue and Forecast, by Technology

12.4.7.4. Market Revenue and Forecast, by End-User Industry

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Method

12.4.8.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.4.8.3. Market Revenue and Forecast, by Technology

12.4.8.4. Market Revenue and Forecast, by End-User Industry

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Method

12.5.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.5.3. Market Revenue and Forecast, by Technology

12.5.4. Market Revenue and Forecast, by End-User Industry

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Method

12.5.5.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.5.5.3. Market Revenue and Forecast, by Technology

12.5.5.4. Market Revenue and Forecast, by End-User Industry

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Method

12.5.6.2. Market Revenue and Forecast, by Toxicity Endpoint & Test

12.5.6.3. Market Revenue and Forecast, by Technology

12.5.6.4. Market Revenue and Forecast, by End-User Industry

Chapter 13. Company Profiles

13.1. Laboratory Corporation of America Holdings

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Charles River Laboratories, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bureau Veritas

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Eurofins Scientific

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Pharmaceutical Product Development, LLC

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Envigo

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Merck KGaA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. SGS Group

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Evotec AG

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. WuXi AppTech

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms